Less than 20 years ago, lymphadenectomy and lymph node dissection were primarily used as staging procedures. Today, studies have shown that the procedures can increase the survival rates in patients with a host of urologic cancers. In this exclusive interview, Urs Studer, MD, professor and chairman of the department of urology, University of Bern, Switzerland, discusses the expanding role of lymph node dissection in bladder, prostate, and kidney cancer. The interview was conducted by UT Editorial Consultant Robert C. Flanigan, MD, professor and chairman of the department of urology at Loyola University Medical Center, Maywood, IL.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.